ROLE OF TARGETED THERAPY IN THE COMBINATION TREATMENT OF PATIENTS WITH KIDNEY CANCER AND METASTATIC BRAIN INVOLVEMENT

In patients with kidney cancer (KC), the rate of metastatic brain involvement is 2-11%, is steadily growing, and is one of the important reasons for treatment failures in these patients. Surgery and radiotherapy, including radiosurgery, must be considered as optimal treatments for patients with KC a...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: D. R. Naskhletashvili, V. A. Gorbunova, A. Kh. Bekyashev, V. B. Karakhan, E. A. Moskvina, E. V. Prozorenko
Formatua: Artigo
Hizkuntza:Russo
Argitaratua: ABV-press 2015-04-01
Saila:Opuholi Golovy i Šei
Gaiak:
kidney cancer
brain metastases
targeted therapy
Sarrera elektronikoa:https://ogsh.abvpress.ru/jour/article/view/127
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak